Cancer Investigation : Impact Factor & More
eISSN: 1532-4192pISSN: 0735-7907
Share this on:
Aims and Scope of Cancer Investigation
Cancer Investigation is a peer-reviewed medical journal in the field of basic and clinical oncology. The editor in chief is Gary Lyman. It is currently indexed for MEDLINE.
Key Metrics
CiteScore 
3.2
H-Index
90
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.61
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Investigation
Cancer Investigation Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1983 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Investigation ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Investigation
Systematic Review and Single-Arm Meta-Analysis of Bevacizumab Combined with Chemotherapy or Immunotherapy for Oncological Outcomes in Advanced/Recurrent Ovarian Clear Cell Carcinoma
- 23 Feb 2026
- Cancer Investigation
Investigation of Adverse Response Expressions to Immune Checkpoint Inhibitor Therapy in PD1-Expressing Non-Small Cell Lung Cancer Patients
- 19 Feb 2026
- Cancer Investigation
Dysphagia Outcomes Following Chimeric Antigen Receptor T-Cell (CAR-T) Treatment in Patients with Non-Hodgkin Lymphoma
- 6 Feb 2026
- Cancer Investigation
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study
- 5 Feb 2026
- Cancer Investigation
Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective Study
- 2 Feb 2026
- Cancer Investigation
Prognostic Significance of Different Ki-67 Cutoff Values Defined Luminal B HER2-Negative Breast Cancer
- 2 Feb 2026
- Cancer Investigation
Systematic Review and Single-Arm Meta-Analysis of Bevacizumab Combined with Chemotherapy or Immunotherapy for Oncological Outcomes in Advanced/Recurrent Ovarian Clear Cell Carcinoma
- 23 Feb 2026
- Cancer Investigation
Investigation of Adverse Response Expressions to Immune Checkpoint Inhibitor Therapy in PD1-Expressing Non-Small Cell Lung Cancer Patients
- 19 Feb 2026
- Cancer Investigation
Dysphagia Outcomes Following Chimeric Antigen Receptor T-Cell (CAR-T) Treatment in Patients with Non-Hodgkin Lymphoma
- 6 Feb 2026
- Cancer Investigation
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study
- 5 Feb 2026
- Cancer Investigation
Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective Study
- 2 Feb 2026
- Cancer Investigation
Prognostic Significance of Different Ki-67 Cutoff Values Defined Luminal B HER2-Negative Breast Cancer
- 2 Feb 2026
- Cancer Investigation
FAQs on Cancer Investigation
How long has Cancer Investigation been actively publishing? 
What is the publishing frequency of Cancer Investigation?
How many articles did Cancer Investigation publish last year?
What is the eISSN & pISSN for Cancer Investigation?
What is Citescore for Cancer Investigation?
What is the H Index for Cancer Investigation ?
What is SNIP score for Cancer Investigation?
What is the SJR for Cancer Investigation?
Who is the publisher of Cancer Investigation?
